GS0401: Manufacturing services to the specification of others in the pharmaceutical field and in the veterinary field, in particular in the field of pharmaceutical active substance delivery systems, including customized release, taste masked release, immediate release, pulsatile release, extended release, sustained release, and delayed release systems; clinical manufacturing of drug compositions for others to support clinical trials; manufacturing process consulting services for others relating to technology scale-up and integration of technology into manufacturing processes
B00001: In the statement, line 14 - 15, "thrombonemia, ipertriglyceremia, ipercholesterolemia, iperlipoproteinemia" should be deleted, and "thrombocythemia, hypertriglyceridemia, hypercholesterolemia, hyperlipoproteinemia, should be inserted. line 20, "Alzheimer" should be deleted, and "Alzheimer's" should be inserted.
GS0051: Pharmaceutical and veterinary pharmaceutical preparations, in particular drug delivery compositions, drug carriers and drug delivery agents, capsules, sachets and sprinkles for pharmaceutical purposes, comprising multiparticulates or multiple units, used for the treatment of disorders or diseases in the gastrointestinal tract, in the digestive system, in the gut, in the immune systems, in the cardiovascular system, in the respiratory tract, in the blood, in the metabolism, in the nervous system, in the cognition, in the behavior, and in the reproductive tract, gastrointestinal infections, diarrhea, irritable bowel syndrome, inflammatory bowel syndrome disease, enterocolitis, enteritis, ulcerative colitis, cardiovascular disorders, hypertension, thrombosis, vasoconstriction, asthma, inflammation of respiratory tract, asthma, bronchoconstriction, [ thrombonemia, ipertriglyceremia, ipercholesterolemia, iperlipoproteinemia, ] * thrombocythemia ,hypertriglyceridemia, hypercholesterolemia, hyperlipoproteinemia, * blood anemia, hypocalcemia, diabetes, diabetic peripheral neuropathy, dyskinesia, hyperkinetic movements, enzyme deficiency, pancreatitis, pancreatectomy, steatorrhea, cystic fibrosis, Paget's disease, bacterial infections, viral infections, fungal infections, osteoporosis, cancer, mucosal and systemic inflammation, functional disease, abdominal pain, allergy, obesity, muscle spasticity, spasms, convulsion, dysthymia, schizophrenia, degenerative dementia, [ Alzheimer, ] * Alzheimer's, * stress, anxiety, depression, mood disturbance, sociability disturbance, sleep disturbance, psychological disturbance, attention deficit hyperactivity disorder, addiction, fibromyalgia, obsessive-compulsive disorders, pain, peripheral neuropathic pain, post-surgical pain, back-pain, osteoarthritis
DS0000: "MULTI MINI TABLET SYSTEM"
GS0421: Research and development services in the pharmaceutical field and in the veterinary field, in particular in the field of pharmaceutical active substance delivery systems; research and development services for the preparation of multiparticulates or multiple units dosage forms including capsules, sachets, sprinkles; research and development in the area of delivery systems with customized release, taste masked release, immediate release, pulsatile release, extended release, sustained release, and delayed release; scientific research and development in the area of stability testing, physical characterization, in-vitro release testing
Case File Event Statements
11/26/2022 - 3 years ago
1 - NEW APPLICATION ENTEREDType:NWAP
12/15/2022 - 3 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTEREDType:NWOS
9/6/2023 - 2 years ago
3 - ASSIGNED TO EXAMINERType:DOCK
9/12/2023 - 2 years ago
4 - NON-FINAL ACTION WRITTENType:CNRT
9/12/2023 - 2 years ago
5 - NON-FINAL ACTION E-MAILEDType:GNRT
9/12/2023 - 2 years ago
6 - NOTIFICATION OF NON-FINAL ACTION E-MAILEDType:GNRN
12/12/2023 - 2 years ago
7 - TEAS RESPONSE TO OFFICE ACTION RECEIVEDType:TROA
5/2/2024 - a year ago
8 - ASSIGNED TO LIEType:ALIE
5/2/2024 - a year ago
9 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
5/2/2024 - a year ago
10 - TEAS/EMAIL CORRESPONDENCE ENTEREDType:TEME
5/6/2024 - a year ago
11 - EXAMINERS AMENDMENT -WRITTENType:CNEA
5/6/2024 - a year ago
12 - EXAMINERS AMENDMENT E-MAILEDType:GNEA
5/6/2024 - a year ago
13 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILEDType:GNEN
5/6/2024 - a year ago
14 - EXAMINER'S AMENDMENT ENTEREDType:XAEC
5/6/2024 - a year ago
15 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
5/22/2024 - a year ago
16 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILEDType:NONP
6/11/2024 - a year ago
17 - PUBLISHED FOR OPPOSITIONType:PUBO
6/11/2024 - a year ago
18 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILEDType:NPUB
12/5/2024 - a year ago
25 - TEAS CHANGE OF CORRESPONDENCE RECEIVEDType:TCCA
8/6/2024 - a year ago
19 - NOA E-MAILED - SOU REQUIRED FROM APPLICANTType:NOAM
12/5/2024 - a year ago
22 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVEDType:REAP